GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Apures Co Ltd (XKRX:149300) » Definitions » Inventories, Other

Apures Co (XKRX:149300) Inventories, Other : ₩-0.0 Mil (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Apures Co Inventories, Other?

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. Apures Co's other inventories for the quarter that ended in Dec. 2023 was ₩-0.0 Mil.

Apures Co's quarterly other inventories declined from Dec. 2021 (₩0.0 Mil) to Dec. 2022 (₩0.0 Mil) and declined from Dec. 2022 (₩0.0 Mil) to Dec. 2023 (₩-0.0 Mil).

Apures Co's annual other inventories declined from Dec. 2021 (₩0.0 Mil) to Dec. 2022 (₩0.0 Mil) and declined from Dec. 2022 (₩0.0 Mil) to Dec. 2023 (₩-0.0 Mil).


Apures Co Inventories, Other Historical Data

The historical data trend for Apures Co's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apures Co Inventories, Other Chart

Apures Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Other
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Apures Co Semi-Annual Data
Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Other Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Apures Co Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.


Apures Co (XKRX:149300) Business Description

Traded in Other Exchanges
N/A
Address
44, Hansan-gil, Cheongbuk-eup, Gyeonggi-do, Pyeongtaek-si, KOR, 17792
Apures Co Ltd is a South Korea based company engaged in the development of transgenic animals to support bio heterogeneous long-term commercialization and new drug efficacy research. It has focused its research capabilities on developing transgenic mini pigs based on gene editing technology and somatic cell nuclear transfer technology.

Apures Co (XKRX:149300) Headlines

No Headlines